Atlas Trials

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Clinical trial NCT04415697 · COMPLETED

Trial details

NCT number
NCT04415697
Sponsor
Barretos Cancer Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney CancerBiomarkersGene Expression
Start date
2019-01-02
Primary completion
2020-02-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.